Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer

Annals of Surgical Oncology

Volumn 18, Issue 5, 2011, Pages 1506-1511

  Truong, Matthew ^a,b   Cook, MacKenzie R ^a,b   Pinchot, Scott N ^a,b   Kunnimalaiyaan, Muthusamy ^a,b   Chen, Herbert ^a,b,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c University of Wisconsin Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CHROMOGRANIN A; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NOTCH2 RECEPTOR; RESVERATROL; TETRAZOLIUM; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MASH1;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DISEASE MARKER; DOSE RESPONSE; GROWTH INHIBITION; HORMONE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; MEDULLARY CARCINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CANCER; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BLOTTING, WESTERN; CARCINOMA, MEDULLARY; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMOGRANIN A; HUMANS; NEUROSECRETORY SYSTEMS; POLY(ADP-RIBOSE) POLYMERASES; RECEPTOR, NOTCH2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STILBENES; THYROID NEOPLASMS;

EID: 79955824831     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1488-z     Document Type: Article

References (30)

1. RS Sippel JE Carpenter M Kunnimalaiyaan, et al. 2003 The role of human achaete-scute homolog-1 in medullary thyroid cancer cells Surgery 134 866 871 14668716 10.1016/S0039-6060(03)00418-5 (Pubitemid 38010730)
2. L Giovanella S Crippa L Cariani 2008 Serum calcitonin-negative medullary thyroid carcinoma: role of CgA and CEA as complementary markers Int J Biol Markers 23 129 131 18629788 1:STN:280:DC%2BD1cvltlOrtQ%3D%3D
3. E Seregni L Ferrari E Bajetta, et al. 2001 Clinical significance of blood chromogranin A measurement in neuroendocrine tumours Ann Oncol 12 Suppl 2 S69 S72 11762355 10.1023/A:1012434005852
4. P Tomassetti M Migliori P Simoni, et al. 2001 Diagnostic value of plasma chromogranin A in neuroendocrine tumours Eur J Gastroenterol Hepatol 13 55 58 11204811 10.1097/00042737-200101000-00010 1:STN:280:DC%2BD3M7nvVKlsg%3D%3D (Pubitemid 32099569)
5. H Chen J Hardacre A Uzar, et al. 1998 Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg 187 88 92 9660030 10.1016/S1072-7515(98)00099-4 1:STN:280:DyaK1czitFCltQ%3D%3D (Pubitemid 28303537)
6. H Chen M Kunnimalaiyaan JJ Van Gompel 2005 Medullary thyroid cancer: the functions of raf-1 and human achaete-scute homologue-1 Thyroid 15 511 521 16029117 10.1089/thy.2005.15.511 1:CAS:528:DC%2BD2MXmt1yms70%3D (Pubitemid 40993724)
7. D Giuffrida H Gharib 1998 Current diagnosis and management of medullary thyroid carcinoma Ann Oncol 9 695 701 9739433 10.1023/A:1008242302749 1:STN:280:DyaK1cvhtFOmsg%3D%3D (Pubitemid 28394153)
8. F Quayle J Moley 2005 Medullary thyroid carcinoma: including MEN 2A and MEN 2B syndromes J Surg Oncol 89 122 129 15719378 10.1002/jso.20184 (Pubitemid 40315908)
9. M Pelizzo I Boschin P Bernante, et al. 2007 Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients Eur J Surg Oncol 33 493 497 17125960 10.1016/j.ejso.2006.10.021 1:STN:280:DC%2BD2s3jvVWksg%3D%3D (Pubitemid 46586095)
10. DY Greenblatt AM Vaccaro R Jaskula-Sztul, et al. 2007 Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells Oncologist 12 942 951 17766653 10.1634/theoncologist.12- 8-942 1:CAS:528:DC%2BD2sXhtFWgsbjE (Pubitemid 47359136)
11. E Janson L Holmberg M Stridsberg, et al. 1997 Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center Ann Oncol 8 685 690 9296223 10.1023/A:1008215730767 1:STN:280:DyaK2svkt1Sjtg%3D%3D (Pubitemid 27372168)
12. DW Ball 2004 Achaete-scute homolog-1 and Notch in lung neuroendocrine development and cancer Cancer Lett 204 159 169 15013215 10.1016/S0304-3835(03) 00452-X 1:CAS:528:DC%2BD2cXpsVyntw%3D%3D (Pubitemid 38167719)
13. M Kunnimalaiyaan AM Vaccaro MA Ndiaye, et al. 2006 Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells J Biol Chem 281 39819 39830 17090547 10.1074/jbc.M603578200 1:CAS:528:DC%2BD28XhtlCrtrbP (Pubitemid 46041785)
14. DY Greenblatt MA Cayo JT Adler, et al. 2008 Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells Ann Surg 247 1036 1040 18520232 10.1097/SLA.0b013e3181758d0e (Pubitemid 351770425)
15. Adler J, Hottinger D, Kunnimalaiyaan M, et al. Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride. J Surg Res. 2010;159:640-4.
16. L Ning DY Greenblatt M Kunnimalaiyaan, et al. 2008 Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells Oncologist 13 98 104 18305053 10.1634/theoncologist.2007-0190 1:CAS:528:DC%2BD1cXktVSgsrk%3D (Pubitemid 351342572)
17. L Ning R Jaskula-Sztul M Kunnimalaiyaan, et al. 2008 Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma Ann Surg Oncol 15 2600 2605 18563491 10.1245/s10434-008-0006-z
18. Pinchot SN, Jaskula-Sztul R, Ning L, et al. Identification and validation of Notch pathway activating compounds through a novel high-throughput screening method. Cancer. (in press).
19. J Baur D Sinclair 2006 Therapeutic potential of resveratrol: the in vivo evidence Nat Rev Drug Discov 5 493 506 16732220 10.1038/nrd2060 1:CAS:528:DC%2BD28XlsV2jur8%3D (Pubitemid 44136961)
20. M Juan M Vinardell J Planas 2002 The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful J Nutr 132 257 260 11823587 1:CAS:528:DC%2BD38XhtFGnsrw%3D (Pubitemid 34135604)
21. A Bishayee 2009 Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials Cancer Prev Res (Phila) 2 409 418 10.1158/1940-6207.CAPR-08-0160 1:CAS:528:DC%2BC3cXptFOisro%3D
22. A Schimmer 2004 Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice Cancer Res 64 7183 7190 15492230 10.1158/0008-5472.CAN-04-1918 1:CAS:528:DC%2BD2cXosFyntr8%3D (Pubitemid 39372048)
23. C Jiang Z Wang H Ganther, et al. 2001 Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells Cancer Res 61 3062 3070 11306488 1:CAS:528:DC%2BD3MXivFGqsLw%3D (Pubitemid 32691955)
24. P Garnier W Ying R Swanson 2003 Ischemic preconditioning by caspase cleavage of poly(ADP-ribose) polymerase-1 J Neurosci 23 7967 7973 12954857 1:CAS:528:DC%2BD3sXnt1Wqt70%3D (Pubitemid 37082448)
25. JJ Van Gompel RS Sippel TF Warner, et al. 2004 Gastrointestinal carcinoid tumors: factors that predict outcome World J Surg 28 387 392 14994141 10.1007/s00268-003-7019-3 (Pubitemid 38525873)
26. S Jiang T Kameya H Asamura, et al. 2004 hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors Mod Pathol 17 222 229 14657947 10.1038/modpathol.3800038 1:CAS:528:DC%2BD2cXmsVOisrk%3D (Pubitemid 41656519)
27. M Kunnimalaiyaan M Ndiaye H Chen 2006 Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002 Surgery 140 1009 1014 17188151 10.1016/j.surg.2006.06.040 (Pubitemid 44940811)
28. N Bhattacharyya 2003 A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma Otolaryngol Head Neck Surg 128 115 123 12574769 10.1067/mhn.2003.2 (Pubitemid 36246129)
29. V Sriuranpong MW Borges RK Ravi, et al. 2001 Notch signaling induces cell cycle arrest in small cell lung cancer cells Cancer Res 61 3200 3205 11306509 1:CAS:528:DC%2BD3MXivFGqtr0%3D (Pubitemid 32691976)
30. H Chen MA Biel MW Borges, et al. 1997 Tissue-specific expression of human achaete-scute homologue-1 in neuroendocrine tumors: transcriptional regulation by dual inhibitory regions Cell Growth Differ 8 677 686 9186001 1:CAS:528:DyaK2sXjvVahtr8%3D (Pubitemid 27276398)